No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
SRPT Sarepta Therapeutics
- 118.970
- -0.500-0.42%
Close Dec 20 16:00 ET
- 119.300
- +0.330+0.28%
Post 20:01 ET
11.36BMarket Cap77.25P/E (TTM)
121.000High118.560Low1.95MVolume119.590Open119.470Pre Close232.72MTurnover2.14%Turnover RatioLossP/E (Static)95.52MShares173.25052wk High9.31P/B10.84BFloat Cap91.34452wk Low--Dividend TTM91.15MShs Float181.830Historical High--Div YieldTTM2.04%Amplitude2.598Historical Low119.161Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Sarepta Awarded $115.2M in Vyondys 53 Patent Case: Report
Mizuho Securities Maintains Sarepta Therapeutics(SRPT.US) With Buy Rating, Maintains Target Price $200
Mizuho Securities Reaffirms Their Buy Rating on Sarepta Therapeutics (SRPT)
Sell Rating on Sarepta Therapeutics Due to Limited LGMD Market Potential and Overestimated Elevidys Projections
4 Biotech Stocks Most Wall Street Analysts Are Bullish About
25 U.S. 'Highest Conviction' Stocks – UBS
Heat List
US
Overall
Symbol
Price
% Chg
No Data